Mitochondrial Disease Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceEssential electron carrier in respiratory chain; may improve energy production; most studied supplement for mito disease
Supporting Studies (1)
FAD precursor; essential for Complex I and II; may benefit specific mutations
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsTransports fatty acids into mitochondria; often deficient in mito disease; may help with energy and muscle symptoms
Supporting Studies (1)
Antioxidant; cofactor for mitochondrial enzymes; may help with oxidative stress
Supporting Studies (1)
Alternative energy substrate; may help buffer ATP in energy-deficient states
Supporting Studies (1)
Multiple B vitamins are mitochondrial cofactors; supports overall energy metabolism
Supporting Studies (1)
Antioxidant; helps protect mitochondrial membranes from oxidative damage
Supporting Studies (1)
Essential cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Mitochondrial diseases are a group of disorders caused by dysfunctional mitochondria - the "powerhouses" of cells that produce energy (ATP). These conditions can be inherited or acquired and affect multiple organ systems, particularly those with high energy demands (brain, muscles, heart).
COMMON PRESENTATIONS:
COMMON SYMPTOMS:
CRITICAL: Mitochondrial diseases require specialist care. This protocol is SUPPORTIVE ONLY.
GENERAL MANAGEMENT:
DRUGS TO AVOID:
* CoQ10 is the most studied supplement and supports electron transport.
* Riboflavin is particularly important for Complex I deficiencies.
* L-Carnitine helps with fatty acid transport and is often low.
Expected timeline: Supplements may provide modest symptom improvement over weeks to months. Disease progression is variable.
Clinical Perspective
Mitochondrial Cytopathies: Heterogeneous group of disorders from respiratory chain dysfunction. Genetics: mtDNA (maternal) or nuclear DNA mutations. Heteroplasmy: variable mutation load affects phenotype. Affected organs: high-energy tissues (brain, muscle, heart, eye, liver). Diagnosis: clinical features, lactate, muscle biopsy (ragged red fibers, COX-negative fibers), genetic testing.
CRITICAL: No cure exists. Management is supportive and symptomatic. Avoid metabolic stressors (fasting, illness, extreme temperatures). Many common drugs are mitochondrial toxins - avoid valproate, aminoglycosides, use statins cautiously. Supplements are empirically used but evidence limited - "mitochondrial cocktail." Specialist care essential. Gene therapy and other treatments under investigation.
* CoQ10 (B-grade): Electron carrier. Systematic review: (PMID: 24268541). 100-600mg daily. Most evidence.
* Riboflavin (B-grade): FAD precursor. Review: (PMID: 27450775). 100-400mg daily. Especially for Complex I.
* L-Carnitine (B-grade): Fatty acid transport. Review: (PMID: 23597877). 30-100mg/kg/day. Secondary deficiency common.
* Alpha-Lipoic Acid (C-grade): Antioxidant; cofactor. Review: (PMID: 26376825). 300-600mg daily.
* Creatine (C-grade): Energy buffer. Review: (PMID: 12679790). 5-10g daily.
* B-Complex (C-grade): Mitochondrial cofactors. Review: (PMID: 27450775). High-potency daily.
* Vitamin E (C-grade): Antioxidant. Review: (PMID: 23075608). 400-800 IU daily.
* Thiamine (C-grade): PDH/KGDH cofactor. Review: (PMID: 25248250). 100-300mg daily.
Assessment targets: Clinical symptoms, exercise tolerance, lactate levels, organ function monitoring (cardiac, vision, hearing), quality of life.
Protocol notes: "Mito cocktail": empirically used combination typically includes CoQ10, carnitine, riboflavin, +/- alpha-lipoic acid, creatine, other B vitamins. Evidence: limited but theoretical rationale; may help some patients. Idebenone: CoQ10 analog; studied in LHON, approved in some countries. Arginine: may help with stroke-like episodes in MELAS. Exercise: supervised graded exercise can improve function; avoid exhaustion. Fasting: avoid prolonged fasting; may need IV dextrose when ill. Fever: manage aggressively; increases metabolic demand. Surgery: anesthetic considerations; avoid propofol, minimize fasting. Genetic counseling: important for family members; prenatal diagnosis available for some. Clinical trials: encourage participation; many ongoing. Diet: some use ketogenic diet; evidence limited. Monitoring: regular assessment of potentially affected organs (heart, vision, hearing). Prognosis: highly variable depending on specific disorder and mutation load.